Galdo Bustos

Galdo Bustos

Auto-generated profile, based on publicly available information

Galdo Bustos

Anatomy and Developmental Biology Program, Institute of Biomedical Sciences, University of Chile, Santiago, Chile

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2019 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
ACAmado Carreras-Sureda
Amado Carreras-Sureda
FJFabián Jaña
Fabián Jaña
HUHery Urra
Hery Urra
SDSylvere Durand
Sylvere Durand
DMDavid E. Mortenson
David E. Mortenson
CHClaudio A. Hetz
Claudio A. Hetz

1 March 2016 in Cell Reports
Verified
Journal Article
Open access
CCCesar Cardenas
Cesar Cardenas
MMMarioly Müller
Marioly Müller
AMAndrew McNeal
Andrew McNeal
ALAlenka Lovy
Alenka Lovy
FJFabian Jaňa
Fabian Jaňa
JFJ. Kevin Foskett
J. Kevin Foskett
In the absence of low-level ER-to-mitochondrial Ca(2+) transfer, ATP levels fall, and AMPK-dependent, mTOR-independent autophagy is induced as an essential survival mechanism in many cell types. Here, we demonstrate that tumorigenic cancer cell lines, transformed primary human fibroblasts, and tumors in vivo respond similarly but that autophagy is insufficient for survival, and cancer cells die while their normal counterparts are spared. Cancer cell death is due to compromised bioenergetics that can be rescued with metabolic substrates or nucleotides and caused by necrosis associated with mitotic catastrophe during their proliferation. Our findings reveal an unexpected dependency on constitutive Ca(2+) transfer to mitochondria for viability of tumorigenic cells and suggest that mitochondrial Ca(2+) addiction is a feature of cancer cells.

4 September 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
FUFelix Urra
Felix Urra
FMFelipe Muñoz
Felipe Muñoz
MCMiguel Cordova-Delgado
Miguel Cordova-Delgado
MRMaría Paz Ramírez
María Paz Ramírez
BPBárbara Peña-Ahumada
Bárbara Peña-Ahumada
RARamiro Araya-Maturana
Ramiro Araya-Maturana
Highly malignant triple-negative breast cancer (TNBC) cells rely mostly on glycolysis to maintain cellular homeostasis; however, mitochondria are still required for migration and metastasis. Taking advantage of the metabolic flexibility of TNBC MDA-MB-231 cells to generate subpopulations with glycolytic or oxidative phenotypes, we screened phenolic compounds containing an ortho-carbonyl group with mitochondrial activity and identified a bromoalkyl-ester of hydroquinone named FR58P1a, as a mitochondrial metabolism-affecting compound that uncouples OXPHOS through a protonophoric mechanism. In contrast to well-known protonophore uncoupler FCCP, FR58P1a does not depolarize the plasma membrane and its effect on the mitochondrial membrane potential and bioenergetics is moderate suggesting a mild uncoupling of OXPHOS. FR58P1a activates AMPK in a Sirt1-dependent fashion. Although the activation of Sirt1/AMPK axis by FR58P1a has a cyto-protective role, selectively inhibits fibronectin-dependent adhesion and migration in TNBC cells but not in non-tumoral MCF10A cells by decreasing β1-integrin at the cell surface. Prolonged exposure to FR58P1a triggers a metabolic reprograming in TNBC cells characterized by down-regulation of OXPHOS-related genes that promote cell survival but comprise their ability to migrate. Taken together, our results show that TNBC cell migration is susceptible to mitochondrial alterations induced by small molecules as FR58P1a, which may have therapeutic implications.

8 September 2017 in Frontiers in Oncology
Verified
Journal Article
Open access
GBGaldo Bustos
Galdo Bustos
PCPablo Cruz
Pablo Cruz
ALAlenka Lovy
Alenka Lovy
CCCesar Cardenas
Cesar Cardenas
Cancer is characterized by an uncontrolled cell proliferation rate even under low nutrient availability, which is sustained by a metabolic reprograming now recognized as a hallmark of cancer. Otto Warburg was the first to establish the relationship between cancer and mitochondria, however, he interpreted enhanced aerobic glycolysis as mitochondrial dysfunction. Today it is accepted that many cancer cell types need fully functional mitochondria to maintain their homeostasis. Calcium (Ca+2) ¬─a key regulator of several cellular processes─ has proven to be essential for mitochondrial metabolism. Inositol 1,4,5-trisphosphate receptor (IP3R)-mediated Ca2+ transfer from the endoplasmic reticulum to the mitochondria through the mitochondrial calcium uniporter (MCU) proves to be essential for the maintenance of mitochondrial function and cellular energy balance. Both, IP3R and MCU are overexpressed in several cancer cell types and the inhibition of the Ca2+ communication between these two organelles causes proliferation arrest, migration decrease and cell death through mechanisms that are not fully understood. In this review, we summarize and analyze the current findings in this area, emphasizing the critical role of Ca2+ and mitochondrial metabolism in cancer and its potential as a novel therapeutic target.

14 July 2020 in Science Signaling
Verified
Journal Article
Closed access
PDF file
Cesar CardenasCesar Cardenas
Cesar Cardenas
ALAlenka Lovy
Alenka Lovy
ESEduardo Silva-Pavez
Eduardo Silva-Pavez
FUFelix Urra
Felix Urra
CMCraig Mizzoni
Craig Mizzoni
JFJ. Kevin Foskett
J. Kevin Foskett
Mitochondrial Ca 2+ influx promotes oxidative phosphorylation–independent pathways to enable cancer cell survival.

1 November 2019 in Mitochondrion
Verified
Journal Article
Closed access
FJFabian Jaña
Fabian Jaña
GBGaldo Bustos
Galdo Bustos
JRJosé Rivas
José Rivas
PCPablo Cruz
Pablo Cruz
FUFelix Urra
Felix Urra
Cesar CardenasCesar Cardenas
Cesar Cardenas